Exhibit 4.05

LOGO

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THE WARRANTS HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED (the “1933 ACT’), OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO YOU THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE 1933 ACT, OR ANY APPLICABLE STATE SECURITIES LAWS.

PLAIN ENGLISH WARRANT AGREEMENT

This is a PLAIN ENGLISH WARRANT AGREEMENT dated February 28, 2008 by and between MOBITV, INC., a Delaware corporation, and TRIPLEPOINT CAPITAL LLC, a Delaware limited liability company.

The words “We”, “Us”, or “Our” refer to the warrant holder, which is TRIPLEPOINT CAPITAL LLC. The words “You” or “Your” refers to the issuer, which is MOBITV, INC., and not to any individual. The words “The Parties” refers to both TRIPLEPOINT CAPITAL LLC and MOBITV, INC. This Plain English Warrant Agreement may be referred to as the “Warrant Agreement”.

The Parties have entered into a Plain English Master Lease Agreement dated as of April 19, 2006; and related Hardware or Software Facility Schedules, and related Summary Schedules which will be collectively referred to as the “Leases”.

In consideration of such Leases, the Parties agree to the following mutual agreements and conditions set forth below:

WARRANT INFORMATION


Effective Date	Warrant Number	Facility Schedules
February 28, 2008	432-W-03	0432-LE-02H; 0432-LE-02S


Warrant Coverage	Number of Shares	Price Per Share	Type of Stock
$80,000	14,679	$5.45	Series B Preferred Stock

OUR CONTACT INFORMATION

Name

Address For Notices

Contact Person

TriplePoint Capital LLC

2755 Sand Hill Rd., Ste. 150

Menlo Park, CA 94025

Tel: (650) 854-2090

Fax: (650) 854-1850

Sajal Srivastava, COO

Tel: (650) 233-2102

Fax: (650) 854-1850

email: legal@triplepointcapital.com

YOUR CONTACT INFORMATION

Customer Name

Address For Notices

Contact Person

MobiTV, Inc.

6425 Christie Avenue, 5th Floor

Emeryville, CA 94608

William Losch, CFO

Tel: (510)450-5077

Fax: (510)868-6472

Email: blosch@mobitv.com

1. WHAT YOU AGREE TO GRANT US.

You grant to Us and We will be entitled, upon the terms and subject to the conditions set forth in this Warrant Agreement, to subscribe to and to purchase from You, at a per share purchase price equal to the Exercise Price, Fourteen Thousand Six Hundred and Seventy-Nine (14,679) fully paid and non-assessable shares of Your Series B Preferred Stock

For purposes of this Warrant Agreement, the following capitalized terms have the meanings given below

“Exercise Price” means $5.45.

“Warrant Stock” means Your Series B Preferred Stock.

The number, character and purchase price of such shares are subject to adjustment as provided in Section 4 hereof.

The Parties agree that this Warrant Agreement to purchase the Warrant Stock has a fair market value equal to $100 and that $100 of the issue price is included as part of the leased value and will be allocable to the Warrant Agreement and the original issue discount on the Lease Agreement shall be considered to be zero.

2. WHEN ARE WE ENTITLED TO PURCHASE YOUR SERIES B PREFERRED STOCK.

The term of this Warrant Agreement shall begin on the Effective Date and our right to purchase Series B Preferred Stock shall be available for the lesser of (i) 7 years from the Effective Date or (ii) 5 years from the effective date of Your initial public offering.

3. HOW WE MAY PURCHASE YOUR SERIES B PREFERRED STOCK.

We may exercise Our purchase rights, in whole or in part, at any time, or from time to time, prior to the expiration of the term of this Warrant Agreement, by giving You a completed and executed Notice of Exercise in the form attached as Exhibit I. Promptly upon receipt of the Notice of Exercise and in any event no later than twenty-one (21) days after you have received Our Notice of Exercise and payment of the aggregate Exercise Price for the shares purchased, You will issue to Us a certificate for the number of shares of Series B Preferred Stock that We have purchased and You will execute the Acknowledgment of Exercise in the form attached hereto as Exhibit II indicating the number of shares which will be available to Us for future purchases, if any.

We may pay for the Series B Preferred Stock by either (i) cash or check, or (ii) by the net issuance method as determined below. If We elect the Net Issuance method, You will issue Series B Preferred Stock using the following formula:

X =Y(A-B)

Where: X = the number of shares of Series B Preferred Stock to be issued to Us.

Y =

the number of shares of Series B Preferred Stock we request to be exercised under this Warrant Agreement.

A =

the fair market value of one share of Series B Preferred Stock.

B =

the Exercise Price.

For purposes of the above calculation, current fair market value of Series B Preferred Stock shall mean with respect to each share of Series B Preferred Stock:

If the exercise is in connection with the initial public offering of Your Common Stock, and if Your registration statement relating to such public offering has been declared effective by the SEC, then the fair market value per share shall be the product of (x) the initial “Price to Public” specified in the final prospectus of the offering and (y) the number of shares of Common Stock into which each share of Series B Preferred Stock is convertible at the time of such exercise;

If this Warrant Agreement is exercised after, and not in connection with the Your initial public offering, and:

=:>> if traded on a securities exchange, the fair market value shall be the product of (x) the average of the closing prices over a five (5) day period ending three (3) days before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Series B Preferred Stock is convertible at the time of such exercise; or

=:> if actively traded over-the-counter, the fair market value shall be the product of (x) the average of the closing bid and asked prices quoted on the NASDAQ system (or similar system) over the five (5) day period ending three (3) days before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Series B Preferred Stock is convertible at the time of such exercise;

=:> if at any time Your Common Stock is not listed on any securities exchange or quoted in the NASDAQ System or the over-the-counter market, the current fair market value of Series B Preferred Stock shall be the product of (x) the fair market value of Your Common Stock, as determined in good faith by Your Board of Directors and (y) the number of shares of Common Stock into which each share of Series B Preferred Stock is convertible at the time of such exercise, unless You shall become subject to a merger, acquisition or other consolidation pursuant to which You are not the surviving party, in which case the fair market value of Series B Preferred Stock shall be deemed to be the value received by the holders of the Your Series B Preferred Stock on a common equivalent basis pursuant to such merger or acquisition.

If at any time the number of authorized but unissued shares of Series B Preferred Stock or other securities issuable upon exercise of this Warrant Agreement shall not be sufficient to effect the exercise of this Warrant Agreement, You will take such corporate action as may be necessary to increase the authorized but unissued shares of Series B Preferred Stock or other securities issuable upon exercise of this Warrant Agreement as shall be sufficient for such purpose.

If We elect to exercise part of the Warrant Agreement, You will promptly issue to Us an amended Warrant Agreement stating the remaining number of shares that are available. All other terms and conditions of that amended Warrant Agreement shall be identical to those contained in this Warrant Agreement.

If at the end of the term of this Warrant Agreement, the fair market value of one share of Warrant Stock (or other security issuable upon the exercise hereof) as determined in accordance herewith is greater than the Exercise Price in effect on such date, then this Warrant Agreement shall automatically be deemed on and as of such date to be converted pursuant to the Net Issuance Method as to all shares of Warrant Stock (or such other securities) for which it shall not previously have been exercised or converted.

4. WHEN WILL THE NUMBER OF SHARES AND EXERCISE PRICE CHANGE.

If You Merge. If at any time there is a reorganization of Your stock (other than a reclassification, exchange or subdivision of Your shares otherwise provided in this Warrant Agreement), or Your merger or consolidation with or into another corporation, whether or not You are the surviving corporation or if You sell or convey all or substantially all of Your assets or stock to any other person (each of these foregoing events referred to as a Merger Event), then, as part of such Merger Event, lawful provision shall be made so that We shall thereafter be entitled to receive, upon exercise of Our rights under this Warrant Agreement, the number of shares of preferred stock or other securities of You or the successor corporation resulting from such Merger Event that would have been issuable if We had exercised Our right under this Warrant Agreement immediately prior to the Merger Event. In any such case,

appropriate adjustment (as determined in good faith by Your Board of Directors) shall be made in the application of the provisions of this Warrant Agreement with respect to Our rights and interest after the Merger Event so that the provisions of this Warrant Agreement (including adjustments of the Exercise Price and number of shares of Series B Preferred Stock purchasable) shall be applicable to the greatest extent possible.

If You Reclassify Your Stock. If at any time You reclassify or exchange Your securities or otherwise, change any of the securities as to which purchase rights under this Warrant Agreement exist into the same or a different number of securities of any other class or classes, this Warrant Agreement will thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities which were subject to the purchase rights under this Warrant Agreement immediately prior to such reclassification, exchange or other change.

If You Subdivide or Combine Your Shares. If at any time You combine Your Series B Preferred Stock, the Exercise Price will be proportionately increased and the number of securities purchasable upon exercise of this Warrant Agreement will be proportionately decreased. If at any time You subdivide Your Series B Preferred Stock, the Exercise Price will be proportionately decreased and the number of securities purchasable upon exercise of this Warrant Agreement will be proportionately increased.

If You Pay Stock Dividends in Shares of Series B Preferred Stock. If at any time You pay a dividend payable in, or make any other distribution (except any distribution specifically provided for in the above paragraphs) of, Your Series B Preferred Stock to Your stockholders, then the Exercise Price shall be adjusted, from and after the record date of such dividend or distribution, to that price determined by multiplying the Exercise Price in effect immediately prior to such record date by a fraction (i) the numerator of which shall be the total number of all shares of Your Series B Preferred Stock outstanding immediately prior to such dividend or distribution, and (ii) the denominator of which shall be the total number of all shares of Your Series B Preferred Stock outstanding immediately after such dividend or distribution. We will thereafter be entitled to purchase, at the Exercise Price resulting from such adjustment, the number of shares of Series B Preferred Stock (calculated to the nearest whole share) obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of shares of B Preferred Stock issuable upon the exercise hereof immediately prior to such adjustment and dividing the product thereof by the Exercise Price resulting from such adjustment.

If You Spend More Than the Commitment Amounts Under the Leases. If Our total cost of equipment leased pursuant to the Facility Schedules listed on Page 1 exceeds $2,000,000, We will have the right to purchase from You, at the Exercise Price (adjusted as set forth herein), an additional number of shares, which number shall be determined by (i) multiplying the amount by which the Our total equipment cost exceeds $2,000,000 by 4%, and (ii) dividing the product by the Exercise Price per share referenced in Section 1 above.

If You Change the Antidilution Rights of the Series B Preferred Stock. All antidilution rights applicable to the Series B Preferred Stock purchasable under this Warrant Agreement are as set forth in Your Certificate of Incorporation, or Charter, as amended through the Effective Date. You will promptly provide Us with any restatement, amendment, modification or waiver of the Certificate of Incorporation or Charter that affects such antidilution rights. If there is an adjustment to the “Series B Conversion Price” (as defined in your Certificate of Incorporation or Charter, as may be amended from time to time), You will provide Us the notice specified in Section 4(j) of Article IV thereof.

5. WE CAN TRANSFER THIS PLAIN ENGLISH WARRANT AGREEMENT.

Subject to the terms and conditions contained in Section 7, We (or any successor transferee) may transfer in whole or in part this Warrant Agreement and all its rights. The number of transfers will not exceed three. You will record the transfer on Your books when You receive Our Notice of Transfer in the form attached hereto as Exhibit III, and Our payment of all transfer taxes and other governmental charges involved in such transfer.

6. WARRANTIES, REPRESENTATIONS, WARRANTIES AND COVENANTS FROM YOU.

=:> Reservation of Series B Preferred Stock. The Series B Preferred Stock issuable upon exercise of Our rights under this Warrant Agreement will be duly and validly reserved and when issued in accordance with the provisions of this Warrant Agreement will be validly issued, fully paid and non-assessable, and will be free of any taxes, liens, charges or encumbrances of any nature whatsoever; provided, however, that the Series B Preferred Stock issuable pursuant to this Warrant Agreement may be subject to restrictions on transfer under state and/or Federal securities laws. Upon Our exercise, You will issue to Us certificates for shares of Series B Preferred Stock without charging Us any tax, or other cost incurred by You in connection with such exercise and the related issuance of shares of Series B Preferred Stock. You will not be required to pay any tax, which may be payable in respect of any transfer involved and the issuance and delivery of any certificate in a name other than TriplePoint Capital LLC.

=:> Due Authority. Your execution and delivery of this Warrant Agreement and the performance of Your obligations hereunder, including the issuance to Us of the right to acquire the shares of Series B Preferred Stock, have been duly authorized by all necessary corporate action on Your part and this Warrant Agreement is not inconsistent with the Your Charter or Bylaws, does not contravene any law or governmental rule, regulation or order applicable to it, does not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument to which You are a party or by which You are bound, and this Warrant Agreement constitutes a legal, valid and binding agreement, enforceable in accordance with its terms.

=:> Consents and Approvals. No consent or approval of, giving of notice to, registration with, or taking of any other action in respect of any state, Federal or other governmental authority or agency is required with respect to the execution, delivery and Your performance of Your obligations under this Warrant Agreement, except for the filing of any required notices pursuant to federal and state securities laws, which filings will be effective by the times required thereby.

=:> Issued Securities. All of Your issued and outstanding shares of Common Stock, Series B Preferred Stock or any other securities as of the date of this Warrant Agreement have been duly authorized and validly issued and are fully paid and nonassessable. All outstanding shares of Common Stock and Series B Preferred Stock as of the date of this Warrant Agreement were issued in full compliance with all Federal and state securities laws. In addition:

Your authorized capital as of the date of this Warrant Agreement consists of (A) 81,287,000 shares of Common Stock, of which 12,685,000 shares of Common Stock are issued and outstanding, and (B) 48,669,133 shares of preferred stock, of which 48,316,623 shares are issued and outstanding.

As of the date of this Warrant Agreement, You have reserved 22,472,484 shares of Common Stock for issuance under Your Stock Incentive Plan, under which options to purchase 15,348,715 shares are outstanding, 470,000 shares of Common Stock for issuance upon exercise of a warrant and 68,807 shares of Preferred Stock for issuance upon exercise of a warrant. Except as otherwise provided in this Warrant Agreement and as noted above, as of the date of this Warrant Agreement, there are no other options, warrants, conversion privileges or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued shares of the Your capital stock or other of Your securities.

Except as set forth in Your Investor’s Rights Agreement, as of the date of this Warrant Agreement, Your shareholders do not have preemptive rights to purchase new issuances of the Your capital stock.

=:> Other Commitments to Register Securities. Except as set forth in this Warrant Agreement and the Investors’ Rights’ Agreement, as of the date of this Warrant Agreement, You are not, pursuant to the terms of any other agreement currently in existence, under any obligation to register under the 1933 Act any of Your presently outstanding securities or any of Your securities which may hereafter be issued.

=:> Exempt Transaction. Subject to the accuracy of Our representations in Section 7 hereof as of the date of exercise of this Warrant Agreement, the issuance of the Series B Preferred Stock upon exercise of this Warrant

Agreement will constitute a transaction exempt from (i) the registration requirements of Section 5 of the 1933 Act, in reliance upon Section 4(2) thereof, and (ii) the qualification requirements of the applicable state securities laws.

=:> Compliance with Rule 144. We propose to sell the Series B Preferred Stock issuable hereunder in compliance with Rule 144 promulgated by the Securities and Exchange Commission. Within ten (10) days of Our request, You agree to furnish Us, a written statement confirming Your compliance with the filing requirements of the Securities and Exchange Commission as set forth in such Rule 144, as may be amended, to the extent You are in compliance with such requirements.

7. OUR REPRESENTATIONS AND COVENANTS TO YOU.

=:> Investment Purpose. The right to acquire Series B Preferred Stock or the Series B Preferred Stock issuable upon exercise of Our rights contained herein and the Common Stock issuable upon conversion will be acquired for investment purposes only and not with a view to the sale or distribution of any part thereof, and We have no present intention of selling or engaging in any public distribution of the same except pursuant to a registration statement or an exemption.

=:> Private Issue. We understand (i) that this Warrant Agreement, the Series B Preferred Stock issuable upon exercise of this Warrant Agreement and the Common Stock issuable upon conversion are not registered under the 1933 Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Warrant Agreement will be exempt from the registration and qualifications requirements thereof, and (ii) that Your reliance on such exemption is predicated on the representations set forth in this Section 7.

=:> Disposition of Our Rights. In no event will We make a disposition of any of Our rights to acquire Series B Preferred Stock or Series B Preferred Stock issuable upon exercise of such rights or the Common Stock issuable upon conversion unless and until (i) We shall have notified You in writing of the proposed disposition, and (ii) the transferee agrees to be bound in writing to the applicable terms and conditions of this Warrant Agreement, and (iii) if You request, We shall have furnished You with an opinion of counsel satisfactory to You and Your counsel to the effect that (A) appropriate action necessary for compliance with the 1933 Act has been taken, or (B) an exemption from the registration requirements of the 1933 Act is available. Notwithstanding the foregoing, the restrictions imposed upon the transferability of any of Our rights to acquire Series B Preferred Stock or Series B Preferred Stock issuable on the exercise of such rights or the Common Stock issuable upon conversion do not apply to transfers from the beneficial owner of any of the aforementioned securities to its nominee or from such nominee to its beneficial owner, and shall terminate as to any particular share of Series B Preferred Stock when (I) such security shall have been effectively registered under the 1933 Act and sold by the holder thereof in accordance with such registration or (2) such security shall have been sold without registration in compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been issued to You at Our request by the staff of the Securities and Exchange Commission or a ruling shall have been issued to the You at Our request by such Commission stating that no action shall be recommended by such staff or taken by such Commission, as the case may be, if such security is transferred without registration under the 1933 Act in accordance with the conditions set forth in such letter or ruling and such letter or ruling specifies that no subsequent restrictions on transfer are required. Whenever the restrictions imposed hereunder shall terminate, as hereinabove provided, the holder of a share of Series B Preferred Stock then outstanding as to which such restrictions have terminated shall be entitled to receive from You, without expense to such holder, one or more new certificates for the Warrant or for such shares of Series B Preferred Stocl\ not bearing any restrictive legend referring to 1933 Act registration or exemption.

=:> Financial Risk. We have such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of Our investment, and have the ability to bear the economic risks of Our investment.

=:> Risk of No Registration. We understand that if You do not register with the Securities and Exchange Commission pursuant to Section 12 of the 1934 Act (the “1934 Act”), or file reports pursuant to Section 15(d), of the 1934 Act, or if a registration statement covering the securities under the 1933 Act is not in effect when We desire to sell (i) the rights to purchase Series B Preferred Stock pursuant to this Warrant Agreement, or (ii) the Series B Preferred Stock issuable upon exercise of the right to purchase, We may be required to hold such securities for an

indefinite period. We also understand that any sale of Our right to purchase Series B Preferred Stock or Series B Preferred Stock which might be made by it in reliance upon Rule 144 under the 1933 Act may be made only in accordance with the terms and conditions of that Rule.

=:> Accredited Investor. We are an “accredited investor” within the meaning of the Securities and Exchange Rule 501 of Regulation D, as presently in effect.

=:> Market Standoff. Upon the written request of You or the managing underwriter at the time of Your IPO We agree to be bound by Section 2.13 of Your Investor’s Rights Agreement (as such agreement may be amended from time to time). As a condition precedent to any transfer or assignment of this Warrant Agreement or any of the securities directly or indirectly issuable on exercise of this Warrant Agreement, the transferee or assignee shall agree in writing with You to be bound by this paragraph.

8. NOTICES YOU AGREE TO PROVIDE US.

You agree to give Us at least fifteen (15) days prior written notice of the following events:

=> If You Pay a Dividend or distribution declaration upon your stock prior to Your IPO.

=> If You offer for subscription pro-rata to the existing stockholders additional stock or other equity rights, You will provide us with written notice at the same time You provided any other existing stockholder of such notice in their capacities as such.

=> If You consummate a Merger Event. However, in the event all Secured Obligations (as defined in the Master Lease Agreement) have been paid in full, You shall provide Us with prior written notice of the Merger Event at the same time You provide the same to existing stockholders in their capacities as such.

=> If You consummate an IPO.

=> If You dissolve or liquidate.

All notices in this Section must set forth such information as is given to all of Your stockholders generally, how the event adjusts either Our number of shares or Our Exercise Price and the method used for such adjustment.

Timely Notice. Your failure to timely provide such notice required above shall entitle Us to retain the benefit of the applicable notice period notwithstanding anything to the contrary contained in any insufficient notice received by Us. The notice period shall begin on the date We actually receive a written notice containing all the information specified above.

9. DOCUMENTS YOU WILL PROVIDE US.

=> Certified Resolutions (upon execution)

=> Certificate of Incorporation

=> Investor’s Rights Agreement

=> By Laws

=> Other documents as We may from time to time reasonably request.

10. OTHER LEGAL PROVISIONS THE PARTIES WILL ABIDE BY.

Effective Date. This Warrant Agreement shall be construed and shall be given effect in all respects as if it had been executed and delivered by the Parties on the date hereof. This Warrant Agreement shall be binding upon any ofthe successors or assigns of the Parties.

Attorney’s Fees. In any litigation, arbitration or court proceeding between the Parties relating to this Warrant Agreement, the prevailing party shall be entitled to attorneys’ fees and expenses and all costs of proceedings incurred in enforcing this Warrant Agreement.

Governing Law. This Warrant Agreement shall be governed by and construed for all purposes under and in accordance with the laws of the State of California.

Consent To Jurisdiction And Venue. All judicial proceedings arising in or under or related to this Warrant Agreement may be brought in any state or federal court of competent jurisdiction located in the State of California. By execution and delivery of this agreement, each party hereto generally and unconditionally: (a) consents to personal jurisdiction in San Mateo County, State of California; (b) waives any objection as to jurisdiction or venue in San Mateo County, State of California; (c) agrees not to assert any defense based on lack of jurisdiction or venue in the aforesaid courts; and (d) irrevocably agrees to be bound by any judgment rendered thereby in connection with this Plain English Warrant Agreement. Service of process on any party hereto in any action arising out of or relating to this agreement shall be effective if given in accordance with the requirements for notice set forth in this Section, and shall be deemed effective and received as set forth therein. Nothing herein shall affect the right to serve process in any other manner permitted by law or shall limit the right of either party to bring proceedings in the courts of any other jurisdiction.

Mutual Waiver Of Jury Trial. Because disputes arising in connection with complex financial transactions are most quickly and economically resolved by an experienced and expert person and The Parties wish applicable state and federal laws to apply (rather than arbitration rules), The Parties desire that their disputes be resolved by a judge applying such applicable laws. EACH OF THE PARTIES SPECIFICALLY WAIVES ANY RIGHT THEY MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM (COLLECTIVELY, “CLAIMS”) ASSERTED BY YOU AGAINST US OR OUR ASSIGNEE OR BY US OR OUR ASSIGNEE AGAINST YOU. IN THE EVENT THAT THE FOREGOING JURY TRIAL WAIVER IS NOT ENFORCEABLE, ALL CLAIMS, INCLUDING ANY AND ALL QUESTIONS OF LAW OR FACT RELATING THERETO, SHALL, AT THE WRITTEN REQUEST OF ANY PARTY, BE DETERMINED BY JUDICIAL REFERENCE PURSUANT TO THE CALIFORNIA CODE OF CIVIL PROCEDURE (“REFERENCE”). THE PARTIES SHALL SELECT A SINGLE NEUTRAL REFEREE, WHO SHALL BE A RETIRED STATE OR FEDERAL JUDGE. IN THE EVENT THAT THE PARTIES CANNOT AGREE UPON A REFEREE, THE REFEREE SHALL BE APPOINTED BY THE COURT. THE REFEREE SHALL REPORT A STATEMENT OF DECISION TO THE COURT. NOTHING IN THIS SECTION SHALL LIMIT THE RIGHT OF ANY PARTY AT ANY TIME TO EXERCISE LAWFUL SELF-HELP REMEDIES, FORECLOSE AGAINST COLLATERAL OR OBTAIN PROVISIONAL REMEDIES. THE PARTIES SHALL BEAR THE FEES AND EXPENSES OF THE REFEREE EQUALLY UNLESS THE REFEREE ORDERS OTHERWISE. THE REFEREE SHALL ALSO DETERMINE ALL ISSUES RELATING TO THE APPLICABILITY, INTERPRETATION, AND ENFORCEABILITY OF THIS SECTION. THE PARTIES ACKNOWLEDGE THAT THE CLAIMS WILL NOT BE ADJUDICATED BY A JURY. This waiver extends to all such Claims, including Claims that involve Persons other than You and Us; Claims that arise out of or are in any way connected to the relationship between You and Us; and any Claims for damages, breach of contract, specific performance, or any equitable or legal relief of any kind, arising out of this Warrant Agreement.

Counterparts. This Warrant Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

Notices. Any notice required or permitted under this Warrant Agreement shall be given in writing and shall be deemed effectively given upon the earlier of (1) actual receipt or 3 days after mailing if mailed postage prepaid by regular or airmail to Us or You or (2) one day after it is sent by overnight mail via nationally recognized courier or (3) on the same day as sent via confirmed facsimile transmission, provided that the original is sent by personal delivery or mail by the sending party.

Remedies. In the event of any default hereunder, the non-defaulting party may proceed to protect and enforce its rights either by suit in equity and/or by action at law, including but not limited to an action for damages as a result of any such default, and/or an action for specific performance for any default where such party will not have an adequate remedy at law and where damages will not be readily ascertainable. Each party expressly agrees that it shall not oppose an application by the other party or any other person entitled to the benefit of this Agreement requiring specific performance of any or all provisions hereof or enjoining such party from continuing to commit any such breach of this Agreement.

No Impairment of Rights. You will not, by amendment of your Charter or through any other means, avoid or seek to avoid the observance or performance of any of the terms of this Warrant Agreement, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate in order to protect Our rights to exercise this Warrant Agreement against impairment.

Survival. The representations, warranties, covenants, and conditions of the Parties contained herein or made pursuant to this Warrant Agreement shall survive the execution and delivery of this Warrant Agreement.

Severability. In the event any one or more of the provisions of this Warrant Agreement shall for any reason be held invalid, illegal or unenforceable, the remaining provisions of this Warrant Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, legal and enforceable provision, which comes closest to the intention of the parties underlying the invalid, illegal or unenforceable provision.

Amendments. Any provision of this Warrant Agreement may only be amended by a written instrument signed by the Parties.

Entire Agreement. This Warrant Agreement constitutes the entire agreement between the Parties pertaining to the subject matter contained in it and supersedes all prior and contemporaneous agreements, representations and undertakings of the Parties, whether oral or written, with respect to such subject matter.

Lost Warrants or Stock Certificates. You covenant to Us that, upon receipt of evidence reasonably satisfactory to Us of the loss, theft, destruction or mutilation of this Warrant Agreement or any stock certificate and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to You, or in the case of any such mutilation upon surrender and cancellation of such Warrant Agreement or stock certificate, You will make and deliver a new Warrant Agreement or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant Agreement or stock certificate.

Facsimile Signatures. This Warrant Agreement may be executed and delivered by facsimile and upon such delivery the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party.

(Signature Page to Follow)

IN WITNESS WHEREOF, each of the Parties have caused this Warrant Agreement to be executed by its officers who are duly authorized as of the Effective Date.


YOU:	MOBITV, INC.

	By:	/s/ WILLIAM E. LOSCH
	Title:	William Losch
		Chief Financial Officer mobitv

US:	TRIPLEPOINT CAPITAL LLC

	By:

	Title:

[SIGNATURE PAGE TO PLAIN ENGLISH WARRANT AGREEMENT 432-W-03]

IN WITNESS WHEREOF, each of the Parties have caused this Warrant Agreement to be executed by its officers who are duly authorized as of the Effective Date.


YOU:	MOBITV, INC.

	By:	/s/ WILLIAM E. LOSCH
	Title:	William Losch
		Chief Financial Officer mobitv

US:	TRIPLEPOINT CAPITAL LLC

	By:	/S/ ILLEGIBLE

	Title:	COO

[SIGNATURE PAGE TO PLAIN ENGLISH WARRANT AGREEMENT 432-W-03]

EXHIBIT I

NOTICE OF EXERCISE

To:

MobiTV, Inc.

We hereby elect to purchase shares of the Series B Preferred Stock of MobiTV, Inc., pursuant to the terms of the Plain English Warrant Agreement dated the_ day of November, 2007 (the “Plain English Warrant Agreement”) between MobiTV, Inc. and Us, and tenders here payment of the purchase price for such shares in full, together with all applicable transfer taxes, if any.

2.	Method of Exercise (Please initial the applicable blank)

The undersigned elects to exercise the Plain English Warrant Agreement by means of a cash payment, and gives You full payment for the purchase price of the shares being purchased, together with all applicable transfer taxes, if any.

The undersigned elects to exercise the Plain English Warrant Agreement by means of the Net

Issuance Exercise method of Section 3 of the Warrant.

3.	In exercising Our rights to purchase the Series B Preferred Stock of MobiTV, Inc., We hereby confirm and acknowledge the investment representations, warranties and covenants made in Section 7 of the Plain English Warrant Agreement.

Please issue a certificate or certificates representing these purchased shares of Series B Preferred Stock in Our name or in such other name as is specified below.





		(Name)


		(Address)


		US: TRIPLEPOINT CAPITAL LLC

		By:

		Title:

		Date:

EXHIBIT II

ACKNOWLEDGMENT OF EXERCISE

MobiTV, Inc., hereby acknowledges receipt of the “Notice of Exercise” from TRIPLEPOINT CAPITAL LLC, to purchase shares of the Series B Preferred Stock of MobiTV, Inc., pursuant to the terms of the Plain English Warrant Agreement, and further acknowledges that shares remain subject to purchase under the terms of the Plain English Warrant Agreement.


YOU:						MobiTV, Inc.

						By:

						Title:

						Date:

EXHIBIT III

TRANSFER NOTICE

FOR VALUE RECEIVED, the foregoing Plain English Warrant Agreement and all rights evidenced thereby are hereby transferred and assigned to



(Please Print)

Whose address is



Dated:

Holder’s Signature:

Holder’s Address:

By signing below, Transferee agrees to be subject to the Warrant Agreement, including the market standoff provisions referred to therein, and hereby makes and agrees to be bound by the investment representations, warranties and covenants made in Section 7 of the Warrant Agreement.



Transferee’s Signature:

Transferee’s Address:

Signature Guaranteed:

NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the Plain English Warrant Agreement, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Plain English Warrant Agreement.

MOBITV INC S-1